Your Voice, Our Headlines

Download Folkspaper App with no Ads!


A fast-growing newspaper curated by the online community.

Russia's Vaccine Is Working! Antibodies Generated In All Second Trial Participants

  • tag_facesReaction
  • Tip Bones

So after all, despite all the hysteria, the coronavirus vaccine is seemingly working. In June and July, Russia had enlisted 76 participants during the first two-stage trials of their vaccine. And as of September 4, 100 percent of participants have developed antibodies to the new coronavirus with no serious side-effects.

"The two 42-day trials - including 38 healthy adults each - did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response," The Lancet said. "Large, long-term trials including a placebo comparison and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection."

Russian President Vladimir Putin had announced on August 13th that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine. The patent Sputnik V vaccine had raised skepticism. This was because the vaccine had not completed its phase-3 trial which involves wide-scale testing with hundreds of participants. However, the new results that have been published in the peer-reviewed journal, and the 40,000-strong later-stage trial that has been launched last week, have answered the critics of the Russian vaccine.

Lead author Dr Naor Bar-Zeev of the International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health in the United States has also shown new hope about the vaccine. He said that the Russian vaccine was encouraging, although the results so far are small to draw a conclusion.